Search for: "Laurence Lai" Results 121 - 140 of 706
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
In undoubtedly one of the most important decisions of the year so far, on 24 August 2021, the English Court of Appeal handed down its judgment in FibroGen v Akebia (FibroGen Inc v Akebia Therapeutics Inc [2021] EWCA Civ 1279), partially allowing FibroGen’s appeal, and so finding one of the ‘Family A’ patents, EP 823, valid and infringed. [read post]
[KEYPOINT]: A historic Federal Court decision says an artificial intelligence system is capable of being named as an “inventor” under the Patents Act 1990, with potentially significant ramifications for technological innovation and the patent system in Australia. [read post]
30 Aug 2021, 12:41 am by Brian Cordery (Bristows)
As many Kluwer readers will know, the last 18 months have witnessed a changing of the guard within the English Patents Court with long-standing first instance judges Arnold and Birss JJ being promoted to the Court of Appeal and their shoes in the Patents Court being filled by the highly respected patent practitioners, Meade and Mellor JJ. [read post]
27 Aug 2021, 1:00 am by Miquel Montañá (Clifford Chance)
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und… [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und… [read post]
23 Aug 2021, 2:12 am by Radhi Shah (USC Gould School of Law)
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und… [read post]
18 Aug 2021, 10:01 am by Neil Eggleston
At the core of the reality here lay questions  that will determine whether millions of renters will be evicted from their homes during a pandemic. [read post]
18 Aug 2021, 6:04 am by Kluwer Patent blogger
” More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und… [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und… [read post]
15 Aug 2021, 11:51 pm by Radhi Shah (USC Gould School of Law)
Legal basis The legal basis for compulsory licenses can be found under the Indian Patent Act, 1970 (Indian Patent Act), Chapter XVI, read with Indian Patent Rules, 2003 (Indian Patent Rules). [read post]
15 Aug 2021, 12:33 pm by Kluwer Patent blogger
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und… [read post]
12 Aug 2021, 6:32 am by Adrian Crespo (Clifford Chance)
  More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und… [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und… [read post]
2 Aug 2021, 8:14 am by Bart van Wezenbeek (Millipede)
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und… [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 [read post]
28 Jul 2021, 3:26 am by Miquel Montañá (Clifford Chance)
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und… [read post]
Almost ten months after India and South Africa sparked the debate on the protection of intellectual property rights with the TRIPS COVID-19 Waiver (IP/C/W/669), there is still no consensus at the TRIPS Council in favour of any action. [read post]
26 Jul 2021, 7:26 am by Bart van Wezenbeek (Millipede)
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und… [read post]
(Dr Enrico Bonadio and Dr Luke McDonagh are Fellows of the Innovators Network Foundation for 2020-21) More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata… [read post]